Future Fields Closes Oversubscribed $8M Series A to Turn Flies Into Bioreactors That Address Undruggable Diseases and Unlock the AI Bio-revolution
Future Fields, the protein biomanufacturing company behind the world's first Drosophila-based EntoEngine™ platform and Instar biofactory, today announced the close